[go: up one dir, main page]

BR9913441B1 - "composto derivado do ácido tiazolínico e uso de um composto derivado do ácido tiazolínico" - Google Patents

"composto derivado do ácido tiazolínico e uso de um composto derivado do ácido tiazolínico"

Info

Publication number
BR9913441B1
BR9913441B1 BRPI9913441-1B1A BR9913441A BR9913441B1 BR 9913441 B1 BR9913441 B1 BR 9913441B1 BR 9913441 A BR9913441 A BR 9913441A BR 9913441 B1 BR9913441 B1 BR 9913441B1
Authority
BR
Brazil
Prior art keywords
tiazolinic
acid derivative
derivative compound
compound
diagnosing
Prior art date
Application number
BRPI9913441-1B1A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9913441A (pt
Inventor
Jr Raymond J Bergeron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9913441A publication Critical patent/BR9913441A/pt
Publication of BR9913441B1 publication Critical patent/BR9913441B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Game Rules And Presentations Of Slot Machines (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BRPI9913441-1B1A 1998-08-31 1999-08-31 "composto derivado do ácido tiazolínico e uso de um composto derivado do ácido tiazolínico" BR9913441B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/144,103 US6083966A (en) 1998-08-31 1998-08-31 Thiazoline acid derivatives
PCT/US1999/019691 WO2000012493A1 (en) 1998-08-31 1999-08-31 Thiazoline acid derivatives

Publications (2)

Publication Number Publication Date
BR9913441A BR9913441A (pt) 2001-10-23
BR9913441B1 true BR9913441B1 (pt) 2013-10-29

Family

ID=22507049

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9913441-1B1A BR9913441B1 (pt) 1998-08-31 1999-08-31 "composto derivado do ácido tiazolínico e uso de um composto derivado do ácido tiazolínico"

Country Status (23)

Country Link
US (9) US6083966A (sh)
EP (1) EP1109795B1 (sh)
JP (3) JP4817498B2 (sh)
KR (1) KR20010074907A (sh)
CN (1) CN100455574C (sh)
AT (1) ATE317392T1 (sh)
AU (1) AU759851B2 (sh)
BR (1) BR9913441B1 (sh)
CA (1) CA2342210C (sh)
CZ (1) CZ2001711A3 (sh)
DE (1) DE69929807T2 (sh)
EA (1) EA200100261A1 (sh)
ES (1) ES2260933T3 (sh)
HU (1) HUP0103165A3 (sh)
IL (2) IL141611A0 (sh)
NO (1) NO321028B1 (sh)
NZ (1) NZ509899A (sh)
PL (1) PL346852A1 (sh)
PT (1) PT1109795E (sh)
TR (1) TR200100541T2 (sh)
UA (1) UA57161C2 (sh)
WO (1) WO2000012493A1 (sh)
YU (1) YU21801A (sh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
CA2344913A1 (en) * 1998-09-21 2000-03-30 University Of Florida Research Foundation, Inc. Antimalarial agents
EP1488791A3 (en) * 1998-09-21 2005-04-06 University Of Florida Research Foundation, Inc. Antimalarial agents
US6806363B1 (en) * 1999-04-16 2004-10-19 Mayo Foundation For Medical Education & Research Cobalamin conjugates useful as antitumor agents
MXPA02003772A (es) 1999-10-15 2005-04-28 Mayo Foundation Conjugados de cobalamina, utiles como agentes para obtencion de imagen y como agentes terapeuticos.
US6689788B1 (en) * 2000-08-25 2004-02-10 University Of Florida Method and composition for treatment of inflammatory bowel disease
EP1334114A2 (en) * 2000-10-25 2003-08-13 Mayo Foundation For Medical Education And Research Transcobalamin binding conjugates useful for treating abnormal cellular proliferation
US6861532B2 (en) 2002-05-15 2005-03-01 Genzyme Corporation Synthesis of 2-alkylcysteine
AU2003263948A1 (en) * 2002-08-22 2004-03-11 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040044220A1 (en) * 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20060069134A1 (en) * 2002-10-01 2006-03-30 Kaneka Corporation Process for producing optically active alpha-substituted cysteine or salt thereof, intermediate therefor, and process for producing the same
US20040185028A1 (en) * 2003-03-19 2004-09-23 Zhenze Hu Antimicrobial compositions containing ethanolamine buffer and biguanide disinfectant
ATE400300T1 (de) * 2003-09-09 2008-07-15 Univ Florida Polyamin-metallchelatbildner-konjugate
AU2003270473A1 (en) * 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
EP1694325A4 (en) * 2003-12-03 2009-03-25 Univ New Jersey Med Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses
WO2005075475A1 (ja) * 2004-02-04 2005-08-18 Shionogi & Co., Ltd. Ｈｉｖインテグラーゼ阻害活性を有するナフチリジン誘導体
PL1866296T3 (pl) 2005-04-04 2017-05-31 University Of Florida Research Foundation, Inc. Polieterowe analogi desferritiocyny
US7365371B2 (en) 2005-08-04 2008-04-29 Cree, Inc. Packages for semiconductor light emitting devices utilizing dispensed encapsulants
AU2007351826A1 (en) * 2006-12-12 2008-10-30 University Of Florida Research Foundation, Inc. Desferrithiocin analogue actinide decorporation agents
US8324397B2 (en) 2007-03-15 2012-12-04 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
MX2011000486A (es) 2008-07-14 2011-08-03 Ferrokin Biosciences Inc Nuevas sales y polimorfos de análogos de desazadesferritiocin polieter como agentes de quelacion metálicos.
US9045440B2 (en) 2010-05-04 2015-06-02 Ferrokin Biosciences, Inc. Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
WO2012157612A1 (ja) * 2011-05-19 2012-11-22 国立大学法人徳島大学 細胞分化誘導剤および分化誘導方法
ES2761200T3 (es) 2011-12-16 2020-05-19 Univ Florida Usos de análogos de 4'-desferritiocina
JP6353751B2 (ja) * 2013-09-25 2018-07-04 国立大学法人電気通信大学 新規複素環式化合物及びその塩、並びに、発光基質組成物
EP3071201A4 (en) * 2013-11-22 2017-04-26 University of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
AU2016255770A1 (en) 2015-04-27 2017-11-16 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274207A (en) 1966-09-20 Processes for preparing thiazole carboxylic acids
US3809754A (en) 1968-12-31 1974-05-07 Medial De Toledo & Cie Method of treating diseases of the mucous membrane using compounds of a thiazolidine carboxylic acid and pharmaceutical preparations thereof
US3882110A (en) 1969-06-11 1975-05-06 Roussel Uclaf Novel 2-alkyl-5-thiazole-carboxylic acid derivatives
FR2062210A5 (sh) 1969-09-17 1971-06-25 Godo Shusei Kk
FR2062120A5 (sh) 1969-10-10 1971-06-25 Messier Fa
FR2141526B1 (sh) 1971-06-14 1975-05-30 Roussel Uclaf
DE2245560A1 (de) 1972-09-16 1974-03-21 Basf Ag Verfahren zur herstellung von 4alkoxycarbonyl-2-thiazolinen
US4430344A (en) 1978-04-08 1984-02-07 Santen Pharmaceutical Co., Ltd. Antihypertensive 4-thiazolidinecarboxylic acids
CS205217B1 (cs) 1979-04-05 1981-05-29 Zdenek Vitamvas Dozimetr ionizujícího záření
DE3002989A1 (de) 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
EP0045281B1 (de) * 1980-07-28 1985-05-08 Ciba-Geigy Ag Thiazolinderivate und Verfahren zu ihrer Herstellung
JPS5758682A (en) * 1980-07-28 1982-04-08 Ciba Geigy Ag Thiazoline derivatives, manufacture and medicinal composition containing same
JPS5772975A (en) 1980-10-24 1982-05-07 Kureha Chem Ind Co Ltd 2-substituted phenylthiazole derviative, and medicine for peptic ulcer containing said derivative as active component
US4367233A (en) 1981-10-02 1983-01-04 American Home Products Corporation Inhibitors of mammalian collagenase
ATE80801T1 (de) 1984-12-18 1992-10-15 Clark Pharma Dev Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln.
HU200177B (en) 1985-06-18 1990-04-28 Biogal Gyogyszergyar Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
US4736060A (en) 1985-08-06 1988-04-05 Nippon Rikagakuyakuhin Co., Ltd. Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl) ethylamine
EP0214933A3 (de) 1985-09-03 1989-05-24 Ciba-Geigy Ag Kombinationspräparate zur Behandlung von Malaria
EP0214101A3 (de) 1985-09-03 1989-05-31 Ciba-Geigy Ag Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
JPS62142168A (ja) 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3735757A1 (de) 1987-10-22 1989-05-03 Degussa Optisch aktive salze aus einem substituierten thiazolidin-4-carboxylat und 3-chlor-2-hydroxypropyltrimethylammonium, deren herstellung und verwendung
DE58906384D1 (de) 1988-01-20 1994-01-27 Ciba Geigy Verfahren zur Herstellung von Komplexverbindungen.
US5182402A (en) 1988-11-07 1993-01-26 Imperial Chemical Industries Plc Herbicidal compositions
GB8826035D0 (en) 1988-11-07 1988-12-14 Ici Plc Herbicidal compositions
US5106992A (en) 1989-07-28 1992-04-21 E. R. Squibb & Sons, Inc. 3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
NL9001955A (nl) 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
US5393777A (en) 1990-11-15 1995-02-28 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Deferration using anguibactin siderophore
DE69132944T2 (de) 1990-11-30 2002-11-21 Otsuka Pharmaceutical Co., Ltd. Azolederivate als Inhibitor von Superoxide-Radikalen
DE69122084T2 (de) 1990-11-30 1997-04-03 Teijin Ltd., Osaka 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
FR2677021B1 (fr) 1991-05-31 1993-10-01 Upsa Laboratoires Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5840739A (en) * 1992-11-16 1998-11-24 University Of Florida Research Foundation, Inc. Thiazoline acid derivatives
AU5602594A (en) * 1992-11-16 1994-06-08 University Of Florida Research Foundation, Inc. 2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives
DE4301356A1 (de) 1993-01-20 1994-07-21 Basf Ag Verfahren zur Herstellung von 2-Alkyl-4-fluormethyl-thiazolcarbonsäure-alkylestern
FR2749583B1 (fr) 1996-06-07 1998-08-21 Lipha Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
US20020049316A1 (en) 1997-04-29 2002-04-25 Halbert Stacie Marie Protease inhibitors
US6373912B1 (en) 1997-06-16 2002-04-16 Legerity, Inc. Phase-locked loop arrangement with fast lock mode
US6174070B1 (en) * 1998-03-02 2001-01-16 Elna Kabushiki Kaisha Portable lighting instrument having a light emitting diode assembly
MA26618A1 (fr) 1998-04-09 2004-12-20 Smithkline Beecham Corp Composes et compositions pharmaceutiques pour le traitement du paludisme
US6147070A (en) 1998-06-05 2000-11-14 Facchini; Francesco Methods and compositions for controlling iron stores to treat and cure disease states
US6083966A (en) * 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
US6159983A (en) 1998-09-18 2000-12-12 University Of Florida Method and composition for treatment of inflammatory bowel disease
CA2344913A1 (en) * 1998-09-21 2000-03-30 University Of Florida Research Foundation, Inc. Antimalarial agents
US6251927B1 (en) 1999-04-20 2001-06-26 Medinox, Inc. Methods for treatment of sickle cell anemia
DE19919336A1 (de) 1999-04-27 2000-11-16 Consortium Elektrochem Ind Verfahren zur Ringspaltung von Thiazolidinderivaten
DE19948434A1 (de) 1999-10-08 2001-06-07 Gruenenthal Gmbh Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
US20040044220A1 (en) 2002-08-22 2004-03-04 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2003263948A1 (en) 2002-08-22 2004-03-11 University Of Florida Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
AU2003270473A1 (en) 2003-09-09 2005-04-27 University Of Florida Desferrithiocin derivatives and their use as iron chelators
ATE400300T1 (de) 2003-09-09 2008-07-15 Univ Florida Polyamin-metallchelatbildner-konjugate
CA2587558A1 (en) 2004-11-19 2006-05-26 Shiva Biomedical, Llc Methods of treating erythropoietin-resistance
PL1866296T3 (pl) 2005-04-04 2017-05-31 University Of Florida Research Foundation, Inc. Polieterowe analogi desferritiocyny
AU2007351826A1 (en) 2006-12-12 2008-10-30 University Of Florida Research Foundation, Inc. Desferrithiocin analogue actinide decorporation agents
US8324397B2 (en) 2007-03-15 2012-12-04 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues

Also Published As

Publication number Publication date
DE69929807D1 (de) 2006-04-20
IL141611A (en) 2006-12-31
IL141611A0 (en) 2002-03-10
JP2002523500A (ja) 2002-07-30
US20030236417A1 (en) 2003-12-25
EP1109795A4 (en) 2002-01-16
AU5789799A (en) 2000-03-21
CA2342210A1 (en) 2000-03-09
CN1313856A (zh) 2001-09-19
US7531563B2 (en) 2009-05-12
JP2011178797A (ja) 2011-09-15
HK1035720A1 (en) 2003-04-24
PL346852A1 (en) 2002-03-11
TR200100541T2 (tr) 2001-11-21
US6559315B1 (en) 2003-05-06
US8008502B2 (en) 2011-08-30
NO20011003L (no) 2001-02-27
US20100094016A1 (en) 2010-04-15
US7126004B2 (en) 2006-10-24
CA2342210C (en) 2009-03-10
DE69929807T2 (de) 2006-11-02
EP1109795B1 (en) 2006-02-08
USRE39132E1 (en) 2006-06-13
ES2260933T3 (es) 2006-11-01
US20070238767A1 (en) 2007-10-11
WO2000012493A9 (en) 2002-04-11
ATE317392T1 (de) 2006-02-15
NO321028B1 (no) 2006-02-27
CZ2001711A3 (cs) 2001-09-12
JP2014065730A (ja) 2014-04-17
EP1109795A1 (en) 2001-06-27
US20050033057A1 (en) 2005-02-10
AU759851B2 (en) 2003-05-01
EA200100261A1 (ru) 2001-10-22
HUP0103165A3 (en) 2003-03-28
JP4817498B2 (ja) 2011-11-16
YU21801A (sh) 2005-07-19
UA57161C2 (uk) 2003-06-16
US6083966A (en) 2000-07-04
US6521652B1 (en) 2003-02-18
JP5520875B2 (ja) 2014-06-11
CN100455574C (zh) 2009-01-28
BR9913441A (pt) 2001-10-23
HUP0103165A2 (hu) 2002-01-28
PT1109795E (pt) 2006-06-30
NZ509899A (en) 2003-12-19
KR20010074907A (ko) 2001-08-09
WO2000012493A1 (en) 2000-03-09
US6525080B1 (en) 2003-02-25
NO20011003D0 (no) 2001-02-27

Similar Documents

Publication Publication Date Title
BR9913441B1 (pt) "composto derivado do ácido tiazolínico e uso de um composto derivado do ácido tiazolínico"
AU7372191A (en) 3,5-di-tertiarybutyl-4-hydroxyphenylemethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
EP0834253A3 (en) Antimicrobial composition
PT914118E (pt) 3,5-difenil-1,2,4-triazoles substituidos e sua utilizacao como quelantes farmaceuticos de metais
DZ2220A1 (fr) Complexes d'inclusion de sels aryl-hétérocycliques.
ATE224374T1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
EP0702293A3 (en) Compiler with improved investigation of interference from areas of life
FI964236L (fi) Diagnostinen kuva-analyysi metallikompleksilla
ES2136887T3 (es) Derivados antifungicos de sordaridina.
RU96101167A (ru) Брассиностероидное производное и его использование в качестве регулятора роста растений
ATE224372T1 (de) Substituierte 6-alkylphenanthridine
TR199800841A2 (xx) �kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.
TW287103B (sh)
ATE184751T1 (de) Fungizide mischungen eines oximethercarbonsäureamids mit azolderivaten
TR200001941T1 (tr) TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri.
TR200103561T2 (tr) Rodanin türevleri ve amiloidlerin önlenmesi ve görüntülenmesinde kullanımları
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
TR200103562T2 (tr) Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri
FI965157A7 (fi) 2-((2,6-dikloorifenyyli)amiini)fenyyliasetoksietikkahapon uudet suolat orgaanisten emäksisten kationien kanssa
ATE212216T1 (de) Oxidationsfärbemittel zum färben von keratinfasern, die eine spezielle kombination von entwicklerkomponenten und alkalisierungsmittel enthalten
DE69609172D1 (de) 3-phenyl-1,4-dialkyl-1,2,4-triazolium salze und ihre verwendung als antidepressiva
TR199700921T1 (xx) �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.
FI970177L (fi) Kuumakammiossa valettava sinkkilejeerinki
TR199902510T2 (xx) 7alfa-metil-17alfa-etinil-estran t�revlerinin aterosklerozun tedavi edilmesi i�in kullan�m�.
KR980001540U (ko) 차량 도어 및 바디의 힌지부 위치확인용 지그

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/10/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)